Evidence map›Paper›PMID 31936128›Full record

ReviewMaterials (Basel, Switzerland)2020

The Role of Magnetic Nanoparticles in Cancer Nanotheranostics.

Maria Ferreira, João Sousa, Alberto Pais, Carla Vitorino

Abstract readReview
In one paragraph

Review in Materials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Effect on Improving COACS omega · 2023
    Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Laser Ablation of NiFeNanomaterials (Basel, Switzerland) · 2022
    Article
  18. Review
  19. Article
  20. Magnetic Nanoparticles Used in Oncology.Materials (Basel, Switzerland) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Maria FerreiraFaculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal.ORCID 0000-0001-5610-1052
João SousaFaculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal.
Alberto PaisCoimbra Chemistry Center, Department of Chemistry, University of Coimbra, 3004-535 Coimbra, Portugal.
Carla VitorinoFaculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal.

Funding

Fundação para a Ciência e a Tecnologia PEst-OE/QUI/UI0313/2014 and POCI-01-0145-FEDER-007630Fundação para a Ciência e a Tecnologia UID/QUI/00313/2019
6 · The paper itself

Abstract

Technological development is in constant progress in the oncological field. The search for new concepts and strategies for improving cancer diagnosis, treatment and outcomes constitutes a necessary and continuous process, aiming at more specificity, efficiency, safety and better quality of life of the patients throughout the treatment. Nanotechnology embraces these purposes, offering a wide armamentarium of nanosized systems with the potential to incorporate both diagnosis and therapeutic features, towards real-time monitoring of cancer treatment. Within the nanotechnology field, magnetic nanosystems stand out as complex and promising nanoparticles with magnetic properties, that enable the use of these constructs for magnetic resonance imaging and thermal therapy purposes. Additionally, magnetic nanoparticles can be tailored for increased specificity and reduced toxicity, and functionalized with contrast, targeting and therapeutic agents, revealing great potential as multifunctional nanoplatforms for application in cancer theranostics. This review aims at providing a comprehensive description of the current designs, characterization techniques, synthesis methods, and the role of magnetic nanoparticles as promising nanotheranostic agents. A critical appraisal of the impact, potentialities and challenges associated with each technology is also presented.

Indexed as

biomedical applicationscancerdiagnosisdrug deliverymagnetic nanoparticlesnanotheranosticstherapy

Identifiers

PMID31936128
PMCPMC7014348

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.